WO2003054015A3 - Verwendung von koagulationsaktivem antithrombin iii zur therapie von angiogenese-abhängigen erkrankungen - Google Patents

Verwendung von koagulationsaktivem antithrombin iii zur therapie von angiogenese-abhängigen erkrankungen Download PDF

Info

Publication number
WO2003054015A3
WO2003054015A3 PCT/DE2002/004438 DE0204438W WO03054015A3 WO 2003054015 A3 WO2003054015 A3 WO 2003054015A3 DE 0204438 W DE0204438 W DE 0204438W WO 03054015 A3 WO03054015 A3 WO 03054015A3
Authority
WO
WIPO (PCT)
Prior art keywords
coagulant
active
therapy
iii
antitrhombin
Prior art date
Application number
PCT/DE2002/004438
Other languages
English (en)
French (fr)
Other versions
WO2003054015A2 (de
Inventor
Ilhan Celik
Oliver Kisker
Original Assignee
Transmit Technologietransfer
Ilhan Celik
Oliver Kisker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transmit Technologietransfer, Ilhan Celik, Oliver Kisker filed Critical Transmit Technologietransfer
Priority to DE20221790U priority Critical patent/DE20221790U1/de
Priority to EP02791606A priority patent/EP1456236A2/de
Priority to US10/497,724 priority patent/US20050070471A1/en
Priority to AU2002357964A priority patent/AU2002357964A1/en
Publication of WO2003054015A2 publication Critical patent/WO2003054015A2/de
Publication of WO2003054015A3 publication Critical patent/WO2003054015A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von antiangiogen wirksamem Antithrombin III aus koagulationsaktivem (nativem) Antithrombin III und die Verwendung von koagulationsaktivem Antithrombin III zu Prophylaxe und Therapie von Erkrankungen.
PCT/DE2002/004438 2001-12-07 2002-12-04 Verwendung von koagulationsaktivem antithrombin iii zur therapie von angiogenese-abhängigen erkrankungen WO2003054015A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE20221790U DE20221790U1 (de) 2001-12-07 2002-12-04 Koagulationsaktives Antithrombin III und dessen Verwendung zur Prophylaxe und Therapie von Angiogenese-abhängigen Erkrankungen
EP02791606A EP1456236A2 (de) 2001-12-07 2002-12-04 Verwendung von koagulationsaktivem antithrombin iii zur therapie von angiogenese-abhängigen erkrankungen
US10/497,724 US20050070471A1 (en) 2001-12-07 2002-12-04 Use of coagulant-active antithrombin iii for the therapy of angiogenesis-dependent diseases
AU2002357964A AU2002357964A1 (en) 2001-12-07 2002-12-04 Use of coagulant-active antitrhombin iii for the therapy of angiogenesis-dependent diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10160133.6 2001-12-07
DE10160133A DE10160133A1 (de) 2001-12-07 2001-12-07 Verwendung von koagulationsaktivem Antithrombin III zur Therapie von Angiogenese-abhängigen Erkrankungen

Publications (2)

Publication Number Publication Date
WO2003054015A2 WO2003054015A2 (de) 2003-07-03
WO2003054015A3 true WO2003054015A3 (de) 2003-09-18

Family

ID=7708356

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2002/004438 WO2003054015A2 (de) 2001-12-07 2002-12-04 Verwendung von koagulationsaktivem antithrombin iii zur therapie von angiogenese-abhängigen erkrankungen

Country Status (5)

Country Link
US (1) US20050070471A1 (de)
EP (1) EP1456236A2 (de)
AU (1) AU2002357964A1 (de)
DE (1) DE10160133A1 (de)
WO (1) WO2003054015A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070084069A (ko) 2004-10-08 2007-08-24 도만티스 리미티드 Ｔｎｆｒ1에 대한 단일 도메인 항체 및 이의 사용 방법
GB0621513D0 (en) 2006-10-30 2006-12-06 Domantis Ltd Novel polypeptides and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020026A2 (en) * 1998-10-08 2000-04-13 Children's Hospital Compositions and methods for inhibiting angiogenesis
EP1075840A2 (de) * 1999-08-13 2001-02-14 Aventis Behring GmbH Verwendung von Antithrombin III zur Prophylaxe und Therapie von Erkrankungen
EP1224941A2 (de) * 2001-01-17 2002-07-24 Aventis Behring GmbH Antithrombin III gegen durch Angiogenese verursachte Erkrankungen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020026A2 (en) * 1998-10-08 2000-04-13 Children's Hospital Compositions and methods for inhibiting angiogenesis
EP1075840A2 (de) * 1999-08-13 2001-02-14 Aventis Behring GmbH Verwendung von Antithrombin III zur Prophylaxe und Therapie von Erkrankungen
EP1224941A2 (de) * 2001-01-17 2002-07-24 Aventis Behring GmbH Antithrombin III gegen durch Angiogenese verursachte Erkrankungen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KISKER OLIVER ET AL: "Generation of multiple angiogenesis inhibitors by human pancreatic cancer.", CANCER RESEARCH, vol. 61, no. 19, 1 October 2001 (2001-10-01), pages 7298 - 7304, XP002244729, ISSN: 0008-5472 *
O'REILLY M S ET AL: "ANTIANGIOGENIC ACTIVITY OF THE CLEAVED CONFORMATION OF THE SERPIN ANTITHROMBIN", SCIENCE, AAAS. LANCASTER, PA, US, vol. 285, 17 September 1999 (1999-09-17), pages 1926 - 1928, XP002135982, ISSN: 0036-8075 *

Also Published As

Publication number Publication date
DE10160133A1 (de) 2003-06-26
AU2002357964A1 (en) 2003-07-09
WO2003054015A2 (de) 2003-07-03
EP1456236A2 (de) 2004-09-15
US20050070471A1 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
WO2003022852A3 (en) Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
HK1068811A1 (en) Substituted oxazolidinones for combinational therapy
WO2002017914A8 (en) Fused pyrrolocarbazoles against inflammation
WO2003070184A3 (en) Sodium channel blockers
AU2002362774A1 (en) Cyclosporin analogs for the treatment of lung diseases
AU2003285091A1 (en) Interferon antagonists useful for the treatment of interferon related diseases
WO2003099217A3 (en) Methods of treating bacterial infections and diseases associated therewith
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
DE50305587D1 (en) 2-heteroarylcarbonsäureamide
ZA200306124B (en) Method of treating of demyelinating diseases or conditions.
AU2001285747A1 (en) Method for the treatment of tobacco
WO2003033557A3 (de) Fluorhaltige copolymere, deren herstellung und verwendung
WO2003018031A3 (en) Single dose azithromycin for treating respiratory infections
WO2003072541A3 (en) Chemical compounds
WO2004048321A8 (de) Phenylsulfoxid- und -sulfon-derivate
WO2003054015A3 (de) Verwendung von koagulationsaktivem antithrombin iii zur therapie von angiogenese-abhängigen erkrankungen
AU2002229986A1 (en) Method of treating neurological diseases
AU2003303217A1 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
WO2003024996A3 (de) Antibakterielle makrozyklen
AU2002254930A1 (en) Novel medicament compositions based on anticholinergic agents and endothelin antagonists
AU2003231959A1 (en) Method and compound for the prophylaxis or treatment of an immunodeficiency condition, such as aids
WO2005047278A3 (de) Substituierte dihydrochinazoline ii
EP1436279B8 (de) Chemische verbindungen
AU2002335992A1 (en) Process for the production of ascopyrone p

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA JP MX NO NZ US ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002791606

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002791606

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10497724

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWR Wipo information: refused in national office

Ref document number: 2002791606

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002791606

Country of ref document: EP